EAT is up +49.38%% since April’24 pick View All Top Buy Picks
Currently predicting for Mon, 1 Jul 2024

Trading levels for RIO1.F

Fibonacci Support & Resistance Levels

Level Price
R3 62.40 1.34%
R2 62.14 0.93%
R1 61.98 0.670%
Price 61.57
S1 61.47 -0.161%
S2 61.31 -0.418%
S3 61.06 -0.83%

Accumulated Volume Support & Resistance Levels

Level Price
R3 63.24 2.71%
R2 63.21 2.66%
R1 63.10 2.48%
Price 61.57
S1 60.68 -1.45%
S2 60.33 -2.01%
S3 59.59 -3.22%

RIO1.F Predictions History

StockInvest.us BE THE FIRST TO PREDICT

The excellent way of becoming a better trader


  • Easy to use
  • Enhance your skills
  • Predict as many as you like
  • Request predictions
  • Gather points
  • Learn to time your buy and sells

I wonder how good you are and if you can beat me?

Now it is your turn to become professional by doing what professionals do - Exercise

Best regards,

Jim - Co-founder of StockInvest.us [ See tutorial video ]

Click to get the best stock tips daily for free!

About Rio Tinto Group

Rio Tinto Group Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... RIO1.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT